As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of SBC Medical Group Holdings Inc. The largest reported stake is Yoshiyuki Aikawa's, at 82.2%. 3 filings are on record since March 10, 2026 (Schedule 13D/A, April 21, 2026).
Sell to companies like SBC Medical Group Holdings Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: Yoshiyuki Aikawa · Percent: 82.2% · SCHEDULE 13D/A
- · Holder: Aikawa Equity Management Co., Ltd. · Percent: 5.2% · SCHEDULE 13G
- · Holder: Yoshiyuki Aikawa · Percent: 85.2% · SCHEDULE 13D/A
SBC Medical Group Holdings Inc has 3 Schedule 13D or 13G filings on record since 2026-03-10. 2 holders' latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 82.2% | 84,304,460 | SCHEDULE 13D/A, 2026-04-21 | 2026-04-19 | |
| Aikawa Equity Management Co., Ltd. | 5.2% | 5,284,500 | SCHEDULE 13G, 2026-03-13 | 2026-03-06 |
Holding shares or following this stake? See who's behind SBC Medical Group Holdings Inc and the warning signs.
Free to see. No signup.
Keep reading
More on SBC Medical Group Holdings Inc and the records around it.
SBC Medical Group Holdings Inc elsewhere on the record
- Leadership changes May 2026
- Who owns it
Watch SBC Medical Group Holdings Inc
Get an email when SBC Medical Group Holdings Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on SBC Medical Group Holdings Inc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on SBC Medical Group Holdings Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SBC Medical Group Holdings Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Purpose of Transaction (Item 4)
Yoshiyuki Aikawa
Item 4 of the Schedule 13D is hereby amended and restated as set forth below: On April 19, 2026, the Reporting Person, as a selling stockholder and the Issuer entered into an underwriting agreement (the "Underwriting Agreement") with Maxim Group LLC, as representative of the underwriters named therein (the "Underwriters"), relating to an underwritten offering of 3,100,000 shares of Common Stock (the "Offering"). The Underwriters purchased the shares of Common Stock from the Reporting Person at a net price of $3.0225 per share. Additionally, pursuant to the Underwriting Agreement, the Reporting Person has granted the Underwriters a 45-day option to purchase up to an additional 465,000 Shares. The Offering closed on April 21, 2026. The Offering was made pursuant to the Issuer's shelf registration statement on Form S-3 (File No. 333-292451), as supplemented by a preliminary prospectus supplement dated April 17, 2026 and final prospectus supplement, dated April 19, 2026. Pursuant to the Underwriting Agreement, the Reporting Person has entered into a lock-up agreement (the "Lock-Up Agreement"), pursuant to which it has agreed with the Underwriters, subject to certain exceptions, for a period of 90 days after the closing, not to, offer, sell, contract to sell, hypothecate, pledge, grant any option, right, or warrant to purchase or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition (whether by …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-04-21; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-10 | Yoshiyuki Aikawa | 85.2% | SCHEDULE 13D/A |
| 2026-03-13 | Aikawa Equity Management Co., Ltd. | 5.2% | SCHEDULE 13G |
| 2026-04-21 | Yoshiyuki Aikawa | 82.2% | SCHEDULE 13D/A |
Questions about who owns SBC Medical Group Holdings Inc
Who owns SBC Medical Group Holdings Inc?
On this page, 2 holders' latest ownership filings report 5% or more of SBC Medical Group Holdings Inc: Yoshiyuki Aikawa (82.2%, Schedule 13D/A, filed 2026-04-21) and Aikawa Equity Management Co., Ltd. (5.2%, Schedule 13G, filed 2026-03-13).
Who are the largest shareholders of SBC Medical Group Holdings Inc?
By the share each holder's latest filing reports, the largest holders of SBC Medical Group Holdings Inc on this page are Yoshiyuki Aikawa (82.2%) and Aikawa Equity Management Co., Ltd. (5.2%).
When did Yoshiyuki Aikawa buy into SBC Medical Group Holdings Inc?
The filings give report dates, not purchase dates. The earliest filing from Yoshiyuki Aikawa on this page is the Schedule 13D/A, filed 2026-03-10, reporting 85.2%; its latest, Schedule 13D/A filed 2026-04-21, reports 82.2%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 3 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for SBC Medical Group Holdings Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 20, 2026 | Leadership change: Mike Sayama departs, Director | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for SBC Medical Group Holdings Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.